India Cell And Gene Therapy CDMO Market (2025-2031) | Share, Competitive Landscape, Analysis, Forecast, Industry, Size & Revenue, Trends, Growth, Value, Outlook, Companies, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India Cell And Gene Therapy CDMO Market Revenues & Volume, 2021 & 2031F

3.3 India Cell And Gene Therapy CDMO Market - Industry Life Cycle

3.4 India Cell And Gene Therapy CDMO Market - Porter's Five Forces

3.5 India Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Phase, 2021 & 2031F

3.6 India Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.7 India Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Indication, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of genetic disorders in India

4.2.2 Growing investments in cell and gene therapy research and development

4.2.3 Favorable government regulations and initiatives to support the biotechnology sector

4.3 Market Restraints

4.3.1 High costs associated with cell and gene therapy development and manufacturing

4.3.2 Limited awareness and adoption of cell and gene therapy in India

4.3.3 Challenges in scaling up production and maintaining quality standards

6.1 India Cell And Gene Therapy CDMO Market, By Phase

6.1.1 Overview and Analysis

6.1.2 India Cell And Gene Therapy CDMO Market Revenues & Volume, By Phase, 2021- 2031F

6.1.3 India Cell And Gene Therapy CDMO Market Revenues & Volume, By Pre-clinical, 2021- 2031F

6.1.4 India Cell And Gene Therapy CDMO Market Revenues & Volume, By Clinical, 2021- 2031F

6.2 India Cell And Gene Therapy CDMO Market, By Product Type

6.2.1 Overview and Analysis

6.2.2 India Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.2.3 India Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene-Modified Cell Therapy, 2021- 2031F

6.2.4 India Cell And Gene Therapy CDMO Market Revenues & Volume, By Cell Therapy, 2021- 2031F

6.3 India Cell And Gene Therapy CDMO Market, By Indication

6.3.1 Overview and Analysis

6.3.2 India Cell And Gene Therapy CDMO Market Revenues & Volume, By Oncology, 2021- 2031F

6.3.3 India Cell And Gene Therapy CDMO Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.3.4 India Cell And Gene Therapy CDMO Market Revenues & Volume, By Neurological disorders, 2021- 2031F

6.3.5 India Cell And Gene Therapy CDMO Market Revenues & Volume, By Rare Diseases, 2021- 2031F

6.3.6 India Cell And Gene Therapy CDMO Market Revenues & Volume, By Others, 2021- 2031F

7.1 India Cell And Gene Therapy CDMO Market Export to Major Countries

7.2 India Cell And Gene Therapy CDMO Market Imports from Major Countries

8.1 Number of clinical trials utilizing cell and gene therapies in India

8.2 Investment trends in cell and gene therapy infrastructure and facilities

8.3 Adoption rate of cell and gene therapy services by healthcare providers in India

9.1 India Cell And Gene Therapy CDMO Market Opportunity Assessment, By Phase, 2021 & 2031F

9.2 India Cell And Gene Therapy CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.3 India Cell And Gene Therapy CDMO Market Opportunity Assessment, By Indication, 2021 & 2031F

10.1 India Cell And Gene Therapy CDMO Market Revenue Share, By Companies, 2024

10.2 India Cell And Gene Therapy CDMO Market Competitive Benchmarking, By Operating and Technical Parameters